Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
An announcement from Spire Healthcare ( (GB:SPI) ) is now available.
Spire Healthcare Group PLC has announced a change in its voting rights, with Bridgemere Securities Limited increasing its stake to 5.5705% from a previous 4.0900%. This adjustment in voting rights could potentially impact the company’s governance and decision-making processes, influencing its strategic direction and stakeholder interests.
The most recent analyst rating on (GB:SPI) stock is a Buy with a £321.00 price target. To see the full list of analyst forecasts on Spire Healthcare stock, see the GB:SPI Stock Forecast page.
Spark’s Take on GB:SPI Stock
According to Spark, TipRanks’ AI Analyst, GB:SPI is a Outperform.
Spire Healthcare’s stock score is driven by strong financial performance, particularly in revenue growth and operational efficiency, despite high leverage and modest net margins. Technical indicators show positive momentum, supporting a favorable outlook. Corporate events contribute positively with strategic initiatives and strong governance, but the high P/E ratio suggests a need for valuation caution.
To see Spark’s full report on GB:SPI stock, click here.
More about Spire Healthcare
Spire Healthcare Group PLC operates in the healthcare industry, providing a range of medical services and treatments. The company focuses on delivering high-quality healthcare services across the UK, catering to both private patients and those referred by the National Health Service (NHS).
Average Trading Volume: 901,001
Technical Sentiment Signal: Sell
Current Market Cap: £841M
Learn more about SPI stock on TipRanks’ Stock Analysis page.